RAPID ONSET CANNABINOID COMPOSITIONS
    2.
    发明公开

    公开(公告)号:US20240245086A1

    公开(公告)日:2024-07-25

    申请号:US18421313

    申请日:2024-01-24

    Applicant: PAX LABS, INC.

    Inventor: Richard RUCKER

    CPC classification number: A23L29/035 A23L2/38 A23L2/395 A23L2/60

    Abstract: The present application describes cannabis formulations for oral ingestion that provide rapid onset time of cannabinoid effects. The cannabinoid formulations can be in solid form (e.g., tablet or powder) or liquid form (e.g., beverage or tincture). In certain embodiments, the solid composition is intended to be ingested directly into the user's mouth, such as on or under the tongue. In other embodiments, the solid composition is intended to be dissolved in a liquid, such as water or another beverage, prior to consumption.

    POWDER BEVERAGE
    3.
    发明公开
    POWDER BEVERAGE 审中-公开

    公开(公告)号:US20240180201A1

    公开(公告)日:2024-06-06

    申请号:US18367770

    申请日:2023-09-13

    CPC classification number: A23L2/02 A23L2/395 A23L5/30

    Abstract: A powder beverage that includes at least one type of dark-green vegetable, wherein a dispersion time measured by the following procedure is 10 min or less: put 100 mL water in a container having a circular truncated cone shape, a bottom having an inner diameter of 55 mm, a top part having an inner diameter of 75 mm, and a height of 100 mm; inject the powder beverage from above 50 mm of the water surface at a rate of 1 g/sec; and measure the time (dispersion time) from when injection of the powder beverage is terminated to when the powder beverage floating on the liquid surface is submerged in the water.

    PROLONGED RELEASE FORMULATION OF CAFFEINE
    8.
    发明公开

    公开(公告)号:US20230225389A1

    公开(公告)日:2023-07-20

    申请号:US18002440

    申请日:2020-12-11

    CPC classification number: A23L33/30 A23L29/045 A23L2/38 A23L2/395

    Abstract: The present invention relates to a prolonged release formulation of caffeine, which comprises of caffeine embedded in a continuous phase of non-polymeric release controlling carrier. The formulation may be optionally comprised of one or more excipients which are acceptable in nutraceutical and food industry. The invention also relates to a process for preparation; wherein caffeine is uniformly distributed throughout the continuous phase of non-polymeric release controlling carrier to get single-phase granules. The formulation releases caffeine through continuous phase of non-polymeric release controlling carrier, wherein about 20 to 60% of caffeine is released in first hour, followed by about 50-90% of release in 4-8 hours and about 70 to 100% of caffeine release in 8-12 hours. Caffeine formulation can advantageously be administered to a subject for achieving stimulant effect through prolonged release of caffeine over entire day.

    COMPOSITIONS FOR PREVENTION AND TREATMENT OF SYMPTOMS ASSOCIATED WITH ALCOHOL CONSUMPTION

    公开(公告)号:US20230051702A1

    公开(公告)日:2023-02-16

    申请号:US17977969

    申请日:2022-10-31

    Applicant: Monir Elias

    Inventor: Monir Elias

    Abstract: A composition for mitigating, treating, and/or preventing symptoms associated with veisalgia. In one embodiment the composition comprises one or more ingredients selected from the group consisting of: dihydromyricetin, N-acetyl cysteine, salicin, quercetin, bromelain, opuntia, potassium, sodium, magnesium, B-vitamins, vitamin C, taurine, caffeine, monk fruit, turmeric, curcumin, ginger root, and black pepper extract. A method for treating symptoms associated with veisalgia is also described. In one embodiment, the composition is administered in liquid or pill form.

Patent Agency Ranking